Back to Search
Start Over
Sorrento acquires lymphatic delivery platform from Kimberly-Clark
- Source :
- M2 Pharma. July 4, 2018
- Publication Year :
- 2018
-
Abstract
- M2 PHARMA-July 4, 2018-Sorrento acquires lymphatic delivery platform from Kimberly-Clark (C)2018 M2 COMMUNICATIONS Sorrento Therapeutics Inc (NASDAQ:SRNE) has acquired the Sofusa lymphatic delivery technology platform from Kimberly-Clark Corporation (NYSE:KMB) for [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- M2 Pharma
- Publication Type :
- News
- Accession number :
- edsgcl.545318928